AACR Project GENIE: powering precision medicine through an international consortium
AACR Project Genie Consortium… - Cancer discovery, 2017 - AACR
Abstract The AACR Project GENIE is an international data-sharing consortium focused on
generating an evidence base for precision cancer medicine by integrating clinical-grade …
generating an evidence base for precision cancer medicine by integrating clinical-grade …
AACR Project GENIE: 100,000 cases and beyond
Abstract The American Association for Cancer Research (AACR) Project Genomics
Evidence Neoplasia Information Exchange (GENIE) is an international pan-cancer registry …
Evidence Neoplasia Information Exchange (GENIE) is an international pan-cancer registry …
[PDF][PDF] Implementing genome-driven oncology
Early successes in identifying and targeting individual oncogenic drivers, together with the
increasing feasibility of sequencing tumor genomes, have brought forth the promise of …
increasing feasibility of sequencing tumor genomes, have brought forth the promise of …
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Precision medicine is an approach that takes into account the influence of individuals'
genes, environment, and lifestyle exposures to tailor interventions. Here, we describe the …
genes, environment, and lifestyle exposures to tailor interventions. Here, we describe the …
[PDF][PDF] Precision oncology: an overview
In this Special Series issue, Journal of Clinical Oncologypresents a systematic assessment
of cancer genomic information and its accelerating clinical impact. In the scientific literature …
of cancer genomic information and its accelerating clinical impact. In the scientific literature …
Tumor-agnostic precision medicine from the AACR GENIE database: clinical implications
Biomarker-driven cancer therapy has revolutionized precision oncology. With a better
understanding of tumor biology, tissue-agnostic targets have been characterized and …
understanding of tumor biology, tissue-agnostic targets have been characterized and …
Implementing personalized cancer genomics in clinical trials
R Simon, S Roychowdhury - Nature reviews Drug discovery, 2013 - nature.com
The recent surge in high-throughput sequencing of cancer genomes has supported an
expanding molecular classification of cancer. These studies have identified putative …
expanding molecular classification of cancer. These studies have identified putative …
Health: make precision medicine work for cancer care
MA Rubin - Nature, 2015 - nature.com
Health: Make precision medicine work for cancer care | Nature Skip to main content Thank you
for visiting nature.com. You are using a browser version with limited support for CSS. To obtain …
for visiting nature.com. You are using a browser version with limited support for CSS. To obtain …
Druggable genome and precision medicine in cancer: current challenges
CA Dupont, K Riegel, M Pompaiah, H Juhl… - The FEBS …, 2021 - Wiley Online Library
The past decades have seen tremendous developments with respect to “specific”
therapeutics that target key signaling molecules to conquer cancer. The key advancements …
therapeutics that target key signaling molecules to conquer cancer. The key advancements …
Precision oncology: the road ahead
Current efforts in precision oncology largely focus on the benefit of genomics-guided
therapy. Yet, advances in sequencing techniques provide an unprecedented view of the …
therapy. Yet, advances in sequencing techniques provide an unprecedented view of the …